Observational and interventional studies suggest that the MD improves insulin sensitivity, lipid metabolism, and body composition, thereby preventing NAFLD and slowing down its progression [7,8]. The gene discussed is INS; the disease is metabolic dysfunction-associated steatotic liver disease.